These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23652452)

  • 41. Standard medical management in secondary prevention of ischemic stroke in China (SMART).
    Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C;
    Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety of off-label stroke treatment with tissue plasminogen activator.
    Kvistad CE; Logallo N; Thomassen L; Waje-Andreassen U; Brøgger J; Naess H
    Acta Neurol Scand; 2013 Jul; 128(1):48-53. PubMed ID: 23311439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke.
    Ani C; Ovbiagele B
    J Neurol Sci; 2010 Jan; 288(1-2):123-8. PubMed ID: 19853862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic syndrome and chronic kidney disease in high-risk Italian hypertensive patients: the I-DEMAND study.
    Leoncini G; Viazzi F; Agabiti Rosei E; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Deferrari G; Pontremoli R
    J Nephrol; 2012; 25(1):63-74. PubMed ID: 21534241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevention of stroke in atrial fibrillation].
    Masjuan J
    Neurologia; 2012 Mar; 27 Suppl 1():1-3. PubMed ID: 22682203
    [No Abstract]   [Full Text] [Related]  

  • 46. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
    Nam HS; Lee KY; Han SW; Kim SH; Lee JY; Ahn SH; Kim DJ; Kim DI; Nam CM; Heo JH
    J Neurol Sci; 2009 Jun; 281(1-2):69-73. PubMed ID: 19304298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
    Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
    J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impairment in glomerular filtration rate or glomerular filtration barrier and occurrence of stroke.
    Ovbiagele B
    Arch Neurol; 2008 Jul; 65(7):934-8. PubMed ID: 18625861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction.
    Chang A; Kramer H
    Nephron Clin Pract; 2011; 119(2):c171-7; discussion c177-8. PubMed ID: 21811078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis.
    Seet RC; Zhang Y; Wijdicks EF; Rabinstein AA
    Arch Neurol; 2011 Nov; 68(11):1454-8. PubMed ID: 22084129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A population-based approach for the definition of chronic kidney disease: the CKD Prognosis Consortium.
    Cirillo M; Lombardi C; Mele AA; Marcarelli F; Bilancio G
    J Nephrol; 2012; 25(1):7-12. PubMed ID: 22038337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Albuminuria, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: the Hoorn Study.
    Hermans MM; Henry RM; Dekker JM; Nijpels G; Heine RJ; Stehouwer CD
    J Hypertens; 2008 Apr; 26(4):791-7. PubMed ID: 18327090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dilemmas in the management of atrial fibrillation in chronic kidney disease.
    Reinecke H; Brand E; Mesters R; Schäbitz WR; Fisher M; Pavenstädt H; Breithardt G
    J Am Soc Nephrol; 2009 Apr; 20(4):705-11. PubMed ID: 19092127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances and challenges in treatment and prevention of ischemic stroke.
    Grossman AW; Broderick JP
    Ann Neurol; 2013 Sep; 74(3):363-72. PubMed ID: 23929628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of stroke in kidney disease.
    Ninomiya T
    Contrib Nephrol; 2013; 179():58-66. PubMed ID: 23652449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages.
    Dad T; Weiner DE
    Semin Nephrol; 2015 Jul; 35(4):311-22. PubMed ID: 26355250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic Kidney Disease is a Risk Factor for Stroke.
    Wyld M; Webster AC
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105730. PubMed ID: 33926795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stroke and cerebrovascular diseases in patients with chronic kidney disease.
    Toyoda K; Ninomiya T
    Lancet Neurol; 2014 Aug; 13(8):823-33. PubMed ID: 25030514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology, thrombolytic management, and outcomes of acute stroke among patients with chronic kidney disease: a systematic review and meta-analysis.
    Zamberg I; Assouline-Reinmann M; Carrera E; Sood MM; Sozio SM; Martin PY; Mavrakanas TA
    Nephrol Dial Transplant; 2022 Jun; 37(7):1289-1301. PubMed ID: 34100934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thrombolysis in acute ischaemic stroke patients with chronic kidney disease.
    Pana TA; Quinn J; Mohamed MO; Mamas MA; Myint PK
    Acta Neurol Scand; 2021 Dec; 144(6):669-679. PubMed ID: 34328648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.